等待開盤 11-19 09:30:00 美东时间
-0.030
-2.83%
Exicure, Inc. (NASDAQ:XCUR, the "Company"))) announced today that it filed a Notification of Late Filing on Form 12b-25 with the Securities and Exchange Commission (the "SEC") with respect to its
11-17 05:01
Exicure agrees to sell its GPC-100 program assets to GPCRT for $4.8 million to maximize stockholder value.
11-11 23:27
Exicure (NASDAQ:XCUR) reported quarterly losses of $(0.29) per share. This is a 159.18 percent decrease over earnings of $0.49 per share from the same period last year.
05-30 05:36
Exicure (NASDAQ:XCUR) reported quarterly losses of $(0.22) per share. This is a 93.51 percent increase over losses of $(3.39) per share from the same period last year.
03-26 04:35
GLMD: 60% | Galmed Pharmaceuticals Plans To Broaden Its Drug Development Activities, Consisting Of Two Additional Programs Over The Next Two Years EWTX: 42% | Edgewise Therapeutics Announced Top-line Data
2024-09-19 20:06
With U.S. stock futures trading higher this morning on Thursday, some of the st...
2024-09-19 14:30
The Dow Jones index closed higher by over 200 points on Monday. When insiders p...
2024-09-17 21:01
Exicure stock is trading higher on Monday after the company entered into debt-for-equity exchange agreements.
2024-09-17 01:43
-Reuters
2024-09-14 04:25
Gainers Theriva Biologics (AMEX:TOVX) shares moved upwards by 34.2% to $6.31 during Monday's pre-market session. The market value of their outstanding shares is at $6.3 million. Emergent BioSolutions (NYSE:EBS) shares rose 17.62% to $10.48. The market value of their outstanding shares is at $549.1 m...
2024-09-02 20:05